🇺🇸 D+Z in United States
1 US adverse-event reports
Safety signals — FAERS
Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.
- Window: 22 April 2025 – 22 April 2026
- Total reports: 1
Most-reported reactions
- Malignant Melanoma — 1 report (100%)
Other Virology / Hepatology approved in United States
Frequently asked questions
Is D+Z approved in United States?
D+Z does not currently have US marketing authorisation in our dataset.
Who is the marketing authorisation holder for D+Z in United States?
Sequential Medicine Ltd is the originator. The local marketing authorisation holder may differ — check the official source linked above.